Kalaris Therapeutics (KLRS) Stock Price & Financial Analysis
Kalaris Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Kalaris Therapeutics
What is the current stock price for KLRS?
As of the latest trading session, KLRS stock trades at $4.38. The 52-week range is $2.14–$11.88, with a day range of $4.30–$6.25.
What is the P/E ratio for KLRS?
The P/E ratio (Price-to-Earnings) for KLRS is shown in the Key Statistics section. This valuation metric helps compare Kalaris Therapeutics, Inc. to industry peers.
Does KLRS pay dividends?
Kalaris Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for KLRS?
Based on 5 analysts, the consensus for KLRS is Buy.
What is the market cap of KLRS?
Kalaris Therapeutics's market capitalization is $103.9M, classifying it as a micro-cap company. Kalaris Therapeutics operates in the Healthcare sector within the Biotechnology industry.